Interferon Alpha for Refractory Pseudophakic Cystoid Macular Edema (Irvine-Gass Syndrome)

References

• Kim SJ, Schoenberger SD, Thorne JE, Ehlers JP, Yeh S, Bakri SJ. Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American academy of ophthalmology. Ophthalmology. 2015;122(11):2159–2168. doi:10.1016/j.ophtha.2015.05.014.
   PubMed Web of Science ®Google Scholar
• Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol. 1966;76:646–661.
   PubMedGoogle Scholar
• Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953;36:599–619.
   PubMed Web of Science ®Google Scholar
• Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998;96:557–634.
   PubMedGoogle Scholar
• Stark WJ Jr., Maumenee AE, Fagadau W, et al. Cystoid macular edema in pseudophakia. Surv Ophthalmol. 1984;28:442–451.
   PubMed Web of Science ®Google Scholar
• Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB. Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg. 1999;25:1492–1497.
   PubMed Web of Science ®Google Scholar
• Lobo C. Pseudophakic cystoid macular edema. Ophthalmologica. 2012;227(2):61–67. doi:10.1159/000331277.
   PubMed Web of Science ®Google Scholar
• Yonekawa Y, Kim IK. Pseudophakic cystoid macular edema. Curr Opin Ophthalmol. 2012;23(1):26–32. doi:10.1097/ICU.0b013e32834cd5f8.
   PubMed Web of Science ®Google Scholar
• Chu CJ, Johnston RL, Buscombe C, et al. Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology. 2016;123(2):316–323. doi:10.1016/j.ophtha.2015.10.001.
   PubMed Web of Science ®Google Scholar
• Gulkilik G, Kocabora S, Taskapili M, Engin G. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity. Can J Ophthalmol. 2006;41(6):699–703. doi:10.3129/i06-062.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Belair ML, Bressler NM, et al. A method of reporting macular edema after cataract surgery using optical coherence tomography. Retina. 2008;28(6):870–876. doi:10.1097/IAE.0b013e318169d04e.
   PubMed Web of Science ®Google Scholar
• Abe T, Hayasaka S, Nagaki Y, Kadoi C, Matsumoto M, Hayasaka Y. Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone. J Cataract Refract Surg. 1999;25:1286–1288.
   PubMed Web of Science ®Google Scholar
• Arevalo JF, Maia M, Garcia-Amaris RA, et al. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American collaborative retina study group results. Ophthalmology. 2009;116(8):1481–7, 7 e1. doi:10.1016/j.ophtha.2009.04.006.
   PubMed Web of Science ®Google Scholar
• Conway MD, Canakis C, Livir-Rallatos C, Peyman GA. Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg. 2003;29:27–33.
   PubMed Web of Science ®Google Scholar
• Flach AJ, Jampol LM, Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol. 1991;112(5):514–519.
   PubMed Web of Science ®Google Scholar
• Negi AK, Browning AC, Vernon SA. Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery: randomized controlled trial. J Cataract Refract Surg. 2006;32(3):468–474. doi:10.1016/j.jcrs.2005.12.102.
   PubMed Web of Science ®Google Scholar
• Pendergast SD, Margherio RR, Williams GA, Cox MS Jr. Vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol. 1999;128:317–323.
   PubMed Web of Science ®Google Scholar
• Shelsta HN, Jampol LM. Pharmacologic therapy of pseudophakic cystoid macular edema: 2010 update. Retina. 2011;31(1):4–12. doi:10.1097/IAE.0b013e3181fd9740.
   PubMed Web of Science ®Google Scholar
• Spitzer MS, Szurman P, Bartz-Schmidt KU. Intravitreal bevacizumab in postoperative pseudophakic cystoid macular edema: does it really work?. J Cataract Refract Surg. 2008;34(6):880. author reply −1. doi:10.1016/j.jcrs.2008.02.030.
   PubMed Web of Science ®Google Scholar
• Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE. Macular edema. Surv Ophthalmol. 2004;49(5):470–490. doi:10.1016/j.survophthal.2004.06.002.
   PubMed Web of Science ®Google Scholar
• Williams GA, Haller JA, Kuppermann BD, et al. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol. 2009;147(6):1048–54, 54 e1-2. doi:10.1016/j.ajo.2008.12.033.
   Web of Science ®Google Scholar
• Yannuzzi LA, Klein RM, Wallyn RH, Cohen N, Katiz I. Ineffectiveness of indomethacin in the treatment of chronic cystoid macular edema. Am J Ophthalmol. 1977;84:517–519.
   PubMed Web of Science ®Google Scholar
• Deuter CM, Gelisken F, Stubiger N, Zierhut M, Doycheva D. Successful treatment of chronic pseudophakic macular edema (Irvine-Gass syndrome) with interferon alpha: a report of three cases. Ocul Immunol Inflamm. 2011;19(3):216–218. doi:10.3109/09273948.2011.562341.
   PubMed Web of Science ®Google Scholar
• Gillies MC, Su T. Interferon-alpha 2b enhances barrier function of bovine retinal microvascular endothelium in vitro. Microvasc Res. 1995;49(3):277–288. doi:10.1006/mvre.1995.1024.
   PubMed Web of Science ®Google Scholar
• Deuter CM, Kötter I, Günaydin I, Stübiger N, Doycheva DG, Zierhut M. Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. Br J Ophthalmol. 2009;93(7):906–913. doi:10.1136/bjo.2008.153874.
   PubMed Web of Science ®Google Scholar